Correlation Between Acumen Pharmaceuticals and Mesoblast
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Mesoblast, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Mesoblast.
Diversification Opportunities for Acumen Pharmaceuticals and Mesoblast
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Acumen and Mesoblast is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Mesoblast go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Mesoblast
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Mesoblast. In addition to that, Acumen Pharmaceuticals is 1.14 times more volatile than Mesoblast. It trades about -0.28 of its total potential returns per unit of risk. Mesoblast is currently generating about 0.02 per unit of volatility. If you would invest 2,012 in Mesoblast on November 4, 2024 and sell it today you would earn a total of 2.00 from holding Mesoblast or generate 0.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 90.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Mesoblast
Performance |
Timeline |
Acumen Pharmaceuticals |
Mesoblast |
Acumen Pharmaceuticals and Mesoblast Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Mesoblast
The main advantage of trading using opposite Acumen Pharmaceuticals and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.Acumen Pharmaceuticals vs. CytomX Therapeutics | Acumen Pharmaceuticals vs. Instil Bio | Acumen Pharmaceuticals vs. Spero Therapeutics | Acumen Pharmaceuticals vs. Assembly Biosciences |
Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |